Heterologous vaccination interventions to reduce pandemic morbidity and mortality: Modeling the US winter 2020 COVID-19 wave
전염병 이환율 및 사망률을 줄이기 위한 이종 백신 개입: 2020년 미국 겨울 COVID-19 물결 모델링
422
[키워드] age
Bacillus
BCG
benefit
Cohort
Control
country
COVID-19
COVID-19 cases
COVID-19 disease
COVID-19 pandemic
cross-protective
dependent on
determine
Drug administration
Effect
effective
Effectiveness
Effects
Evidence
example
growth
Guidance
Health
help
Heterologous
heterologous vaccine
Hospitalization
immune
immunization
immunological
implementation
inactivated
incidence
Infection
infections
infectious disease modeling
Influenza
influenza vaccine
Intervention
malaria
mathematical
mathematical model
modeling
modulate
morbidity
morbidity and mortality
Mortality
nonpharmaceutical intervention
Nonpharmaceutical interventions
nonspecific
pandemic
Pandemics
parameter
Pathogens
polio
Polio vaccine
Population
reduce
reduced
reduction in
Reproduction number
Resilience
SARS-COV-2 infection
shown
Significance
stimulate
the United State
The United States
trained immunity
transmissible variant
transmissible variants
United States
vaccinated individuals
vaccination
Vaccine
Vaccines
variants
Viral
[DOI] 10.1073/pnas.2025448119 PMC 바로가기 [Article Type] 422
[DOI] 10.1073/pnas.2025448119 PMC 바로가기 [Article Type] 422